InvestorsHub Logo
Followers 38
Posts 4476
Boards Moderated 0
Alias Born 10/21/2014

Re: Biobillionair post# 303950

Thursday, 10/08/2020 8:46:56 PM

Thursday, October 08, 2020 8:46:56 PM

Post# of 425912
BB,
I'm in. However, I think the company will already be filing 'new evidence' in case of unsuccessful en banc. This seems to be the best course of action, stalling generic launch (or, any meaningful generic volume anyways). Wait until the last possible moment to file en banc. Then, if accepted for review, keep extending. If denied, then wait until possible moment and then introduce new evidence. Then, SC perhaps?

“Know what you own, and know why you own it”
-P.L.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News